Recent client coverage highlights

IRD logo square
Some of our favourite coverage from Q1 2022


Kazia Therapeutics advances human trials for lead cancer drugs during December quarter.

Click here to read more


CSO Dr Daniel Tillett Talks To Proactive About Recent Kidney Cancer Results.

Click here to watch 


A good night's sleep may be down to bacteria. A Queensland company is pursuing the idea that what’s in your stomach may be causing insomnia.

Click here to read more 

John Kelly spoke with Jack Crnjanin on Joy 94.9 Radio’s Well Well Well podcast about the Atomo HIV self-test and the health and awareness benefits to come from the TGA’s recent amendments to rules.

Click here to listen to the podcast.  


Martin Filz recently spoke with Proactive Investor’s Andrew Scott about Pureprofile and its recent half yearly earnings performance.

Click here to watch


Oventus Medical, incoming CEO, John Cox, speaks with Andrew Scott from Proactive Investors about the innovations and competitive advantage of Oventus’ sleep apnea therapeutic oral device.

Click here to watch